8legs: American college of cardiology

Your Followed Topics

#1 out of 4

New analysis links shingles vaccination to lower one-year risk of major cardiac events in older adults with heart disease.
Study compared 123,411 vaccinated adults with an equal number of unvaccinated controls from 2018–2025.
Vaccinated participants showed lower risk for major adverse cardiac events, death, heart attack, stroke, and heart failure.
Researchers say the protective effects might be greater in those with existing cardiovascular disease.
CDC recommends shingles vaccination for adults 50 and older and for some younger adults with weakened immune systems.
The study analyzed data from 246,822 US adults with atherosclerotic heart disease.
Shingles vaccination's cardioprotective effects add to evidence beyond preventing shingles.
Study presented at the American College of Cardiology’s Annual Scientific Session in New Orleans.
Shingles can lead to clot formation around brain and heart, potentially causing heart attacks and strokes.
The vaccine is associated with risk reductions similar to quitting smoking in this high-risk group.

Vote 0

#2 out of 4

health11h ago

Latest guidelines from the AHA and ACC push for earlier lifestyle-based prevention in dyslipidemia management.
New PREVENT risk calculator helps tailor heart attack and stroke prevention strategies.
Doctors may use CAC scans, Lp(a), and ApoB tests to better gauge cardiovascular risk.
The guidelines advocate five prevention pillars: diet, activity, no tobacco, sleep, and weight management.
Children aged 9–11 should be screened for cholesterol to identify lifelong risk.
Hypertriglyceridemia treatment emphasis may escalate therapy to reduce short-term pancreatitis risk.
New treatments like olezarsen and plozasiran are noted for lowering triglycerides in high-risk patients.
Guidelines stress lifetime risk assessment beginning in adulthood for personalized care.
Universal screening in childhood aims to detect familial hypercholesterolemia early.

Vote 0

#3 out of 4

The AHA and ACC released updated guidelines urging earlier intervention for dyslipidemia with a focus on lifestyle changes.
A new cardiovascular risk calculator, PREVENT, helps estimate 10-year and 30-year risk to guide treatment decisions.
The guidelines call for three additional tests—CAC, Lp(a), and ApoB—to refine risk assessment and therapy decisions.
Hypertriglyceridemia treatment is a focus, with new therapies like olezarsen and plozasiran mentioned.
The guidelines acknowledge cholesterol can begin early in life and recommend universal screening for children aged 9–11.
The guidance endorses additional imaging and blood tests to personalize prevention beyond a standard cholesterol panel.
Experts emphasize that protection comes from small, consistent lifestyle changes over time.
The updates introduce a revised risk calculator and tests to support earlier decision-making on LDL-C lowering.
The article reiterates the link between dyslipidemia and a range of cardiovascular conditions, underscoring early intervention.
The piece notes that the updated guidelines aim to reduce lifetime cardiovascular risk by tailoring care to individual risk profiles.

Vote 0

#4 out of 4

New 2026 guidelines set specific LDL targets by cardiovascular risk level to guide treatment decisions.
Universal Lp(a) screening is now recommended for all adults, used to refine risk assessment.
Coronary artery calcium (CAC) scoring gains prominence for risk assessment, especially in borderline cases.
Clinicians may combine therapies earlier, moving beyond the old rigid stepwise approach.
Guidelines emphasize lifetime cholesterol exposure and earlier intervention for younger adults.
Women's heart health gains formal recognition of reproductive history as a risk factor.
Preeclampsia, gestational diabetes, early menopause, and PCOS are highlighted for risk assessment.
ApoB testing is discussed as a useful risk measure in select populations.
Questions to ask at your next checkup help translate guidelines into action.
Overall takeaway: advocate for your heart health through informed dialogue with clinicians.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.